Second-line antipsychotic

0 marketed 1 in Phase 3

This page covers all Second-line antipsychotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D2 receptor.

Targets

D2 receptor

Phase 3 pipeline (1)